ArQule | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
399	14	0	ARQL

Emcee: noronha	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
149	Unfortunately, I'm not out...yet. Don't quite get it. THe H&Q pre	Dr. Id	-	1/15/1998
148	Cannot believe this stock went as low as 15 today. I am glad to be out.	Mike Winn	-	1/15/1998
147	The H&Q analysts made public predictions before the conference and they pre	Dr. John M. de Castro	-	1/14/1998
146	<..I don't see any great hurry to dump a class biotech because the marke	SteveG	-	1/14/1998
145	You do what you have to do, but ARQL is expected to make money this year and ne	JZGalt	-	1/14/1998
144	I had to take a small loss (- 1 1/2) today and dumped ARQL at 18 1/2. Either t	Mike Winn	-	1/14/1998
143	Article in Forbes hit the subscribers in the past few days. ARQL mentioned in	JZGalt	-	1/13/1998
142	From the article it sounds like they announced what everyone expected them to a	William Nelson	-	1/12/1998
141	Article looks very positive for ARQL. Anyone knows of any biotech out of that	Mike Winn	-	1/12/1998
140	ArQule is lead story in Sunday's Boston Globe Business boston.com EMERGI	nauset	-	1/12/1998
139	Strange. Stock down after presentation. Anybody heard anything about how the	Mike Winn	-	1/12/1998
138	Steve, The H&Q Conference schedule has been revised. The revised schedule	Henry Niman	-	1/12/1998
137	<A> ArQule Advances Product Discovery Collaborations With Major Corporate	SteveG	-	1/12/1998
136	<..Per H&Q schedule, ARQULE will be the first biotech company among thre	SteveG	-	1/10/1998
135	Per H&Q schedule, ARQULE will be the first biotech company among three othe	Mike Winn	-	1/10/1998
134	<..Is Arqule still scheduled to be the first presenter on Jan 12th?..> A	SteveG	-	1/7/1998
133	Anyone knows the schedule for the H&Q Health conference? Is Arqule still s	Mike Winn	-	1/7/1998
132	<A> ArQule, Inc. Granted U.S. Patent for Aminimide Biological Mimetic ME	SteveG	-	1/6/1998
131	The only thing that can explain is the upcoming H&Q Health Care Conference	Mike Winn	-	12/23/1997
130	Anyone out there have any idea what happened yesterday (Monday 12/22) to explai	David Einstein	-	12/23/1997
129	Hi Dave, I take a look at ABSC, it has a market cap of 245M while ARQL has a m	Mike Winn	-	12/19/1997
128	<I'm not down on ARQL, but I own more of ABSC...> I agree that ABSC	SteveG	-	12/19/1997
127	> This is H&Q's Rachel Leheny's #1 pick. A price target of mid t	JZGalt	-	12/19/1997
126	John-I think you missed their powerful optimization process. I regard this as	James Silverman	-	12/18/1997
125	I really like this ARQL business plan. They have their hand in a myriad of deve	Dr. John M. de Castro	-	12/18/1997

Go to reply# or date (mm/dd/yy):